Crossmark

Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia

Crossref DOI link: https://doi.org/10.1186/s12954-018-0253-7

Published Online: 2018-09-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

van Amsterdam, Jan http://orcid.org/0000-0002-8847-4387
Vervloet, Jojanneke

de Weert, Gerdien

Buwalda, Victor J. A.

Goudriaan, Anna E.

van den Brink, Wim
Funding

Funding for this research was provided by:

Municipality of Utrecht
License Information

Text and Data Mining valid from 2018-09-20
More Information

Article History

Received: 5 June 2018

Accepted: 4 September 2018

First Online: 20 September 2018

Ethics approval and consent to participate

: All participants signed an informed consent form. The Medical Ethical Committee of the AMC, University of Amsterdam approved the study. Trial registration: 2014-005540-17NL. Registered 22 October 2014, 2014-005540-17NL 20141215 CTA.xml

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.